Precision Medicine Group is a specialty services company that supports pharmaceutical and life sciences clients throughout every stage of product development and commercialization. Founded in 2012, the company operates globally with 35 locations across North America, Europe, and Asia-Pacific. It offers comprehensive expertise through its two main platforms: Precision for Medicine and Precision Value & Health, which provide scientific research and industry knowledge to aid drug development, clinical trials, economic value demonstration, and market differentiation.

The company integrates advanced lab sciences, translational informatics, regulatory affairs, and clinical trial expertise to accelerate the development of life-improving treatments. Its team comprises scientists, researchers, clinical trial specialists, laboratory technicians, writers, and designers who collaborate both remotely and in high-tech facilities.

Precision Medicine Group also offers services including biomarker-driven research and development, specialty labs, market access strategies, and medical communications. Serving pharmaceutical and life sciences organizations, the company aims to transform the process of bringing new drugs to market with precision medicine at the core.

The company is based in Bethesda, Maryland, providing a strong strategic location for its operations. Precision Medicine Group has also filed patents related to leveraging electronic health record information, highlighting its innovative approach to health informatics and telehealth.

With leadership experienced in private equity and life sciences sectors, Precision Medicine Group stands as a key player in advancing precision medicine solutions and enabling its clients to efficiently navigate drug development and commercialization challenges.